3.74
price down icon4.10%   -0.16
after-market アフターアワーズ: 3.74
loading
前日終値:
$3.90
開ける:
$3.85
24時間の取引高:
743.24K
Relative Volume:
1.06
時価総額:
$153.33M
収益:
$3.64M
当期純損益:
$-87.37M
株価収益率:
-0.8558
EPS:
-4.37
ネットキャッシュフロー:
$-86.46M
1週間 パフォーマンス:
+3.89%
1か月 パフォーマンス:
+30.31%
6か月 パフォーマンス:
-65.69%
1年 パフォーマンス:
-45.40%
1日の値動き範囲:
Value
$3.6626
$3.9099
1週間の範囲:
Value
$3.54
$4.00
52週間の値動き範囲:
Value
$2.10
$14.22

Verastem Inc Stock (VSTM) Company Profile

Name
名前
Verastem Inc
Name
セクター
Healthcare (1182)
Name
電話
(781) 292-4200
Name
住所
117 KENDRICK STREET, NEEDHAM, MA
Name
職員
73
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
VSTM's Discussions on Twitter

Verastem Inc Stock (VSTM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-09-07 再開されました Alliance Global Partners Buy
2022-04-29 再開されました Cantor Fitzgerald Overweight
2022-04-14 開始されました RBC Capital Mkts Outperform
2022-03-09 開始されました Truist Buy
2021-07-01 開始されました Alliance Global Partners Buy
2021-05-24 アップグレード BTIG Research Neutral → Buy
2019-06-20 ダウングレード BTIG Research Buy → Neutral
2019-05-10 ダウングレード Raymond James Outperform → Mkt Perform
2018-07-13 開始されました BTIG Research Buy
2018-05-02 開始されました Seaport Global Securities Buy
2018-03-08 開始されました B. Riley FBR, Inc. Buy
2017-09-07 繰り返されました H.C. Wainwright Buy
2017-04-13 開始されました Oppenheimer Outperform
2017-03-24 繰り返されました H.C. Wainwright Buy
2015-09-29 ダウングレード Cantor Fitzgerald Buy → Hold
2015-09-29 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2015-09-29 ダウングレード Jefferies Buy → Hold
2015-09-29 ダウングレード Raymond James Strong Buy → Outperform
2015-09-28 ダウングレード Mizuho Buy → Neutral
2015-09-28 ダウングレード ROTH Capital Buy → Neutral
2015-09-09 開始されました Raymond James Strong Buy
2015-05-12 繰り返されました UBS Buy
2015-04-08 開始されました H.C. Wainwright Buy
2015-01-23 繰り返されました ROTH Capital Buy
2014-07-08 再開されました Oppenheimer Perform
2014-02-11 開始されました Mizuho Buy
すべてを表示

Verastem Inc (VSTM) 最新ニュース

pulisher
Nov 04, 2024

Chugai PharmaceuticalVerastem Oncology's Announcement Regarding Avutometinib - Marketscreener.com

Nov 04, 2024
pulisher
Nov 02, 2024

Avutometinib With Defactinib for Recurrent KRAS Mutant LGSOC Completes Rolling New Drug Application - Pharmacy Times

Nov 02, 2024
pulisher
Nov 01, 2024

Verastem Oncology submits NDA for ovarian cancer treatment - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Verastem (FRA:2VSA) Owner Earnings per Share (TTM) : -3.30 (As of Jun. 2024) - GuruFocus.com

Nov 01, 2024
pulisher
Oct 31, 2024

Verastem Oncology Completes Rolling NDA Submission to the FDA for Avutometinib Plus Defactinib as a Treatment for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer - StockTitan

Oct 31, 2024
pulisher
Oct 31, 2024

Verastem Oncology to Participate in Upcoming Investor Conferences - BioSpace

Oct 31, 2024
pulisher
Oct 30, 2024

SG Americas Securities LLC Purchases New Position in Verastem, Inc. (NASDAQ:VSTM) - Defense World

Oct 30, 2024
pulisher
Oct 24, 2024

Verastem's SWOT analysis: ovarian cancer drug maker's stock faces pivotal year - Investing.com India

Oct 24, 2024
pulisher
Oct 21, 2024

Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Oct 21, 2024
pulisher
Oct 18, 2024

Verastem preps an NDA as the stock struggles - BioWorld Online

Oct 18, 2024
pulisher
Oct 18, 2024

Verastem's (VSTM) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Verastem Holders Endure Difficult Day, Analysts Holding Firm (VSTM) - AskTraders

Oct 18, 2024
pulisher
Oct 17, 2024

Truist keeps $15 target on Verastem amid sell-off By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 17, 2024

Verastem Advances Cancer Treatment with Promising Trial Results - TipRanks

Oct 17, 2024
pulisher
Oct 17, 2024

Verastem Oncology Presents Positive Updated RAMP 201 Data for Avutometinib and Defactinib Combination in Recurrent Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society (IGCS) 2024 Annual Meeting - StockTitan

Oct 17, 2024
pulisher
Oct 15, 2024

This trade activity should not be overlooked: Verastem Inc (VSTM) - SETE News

Oct 15, 2024
pulisher
Oct 14, 2024

Verastem Inc (VSTM) stock: A year of ups and downs - US Post News

Oct 14, 2024
pulisher
Oct 10, 2024

Verastem CFO sells shares worth $17 to cover tax obligations By Investing.com - Investing.com Canada

Oct 10, 2024
pulisher
Oct 09, 2024

Verastem CFO sells shares worth $17 to cover tax obligations - Investing.com India

Oct 09, 2024
pulisher
Oct 09, 2024

Verastem Oncology Announces Details for the Oral Presentation of the Mature RAMP 201 Data Evaluating Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer at the IGCS 2024 Annual Meeting - StockTitan

Oct 09, 2024
pulisher
Oct 07, 2024

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Oct 07, 2024
pulisher
Oct 05, 2024

Verastem whipsaws after updates for cancer drug combo - MSN

Oct 05, 2024
pulisher
Oct 03, 2024

Taking the lead: Verastem Inc (VSTM) - SETE News

Oct 03, 2024
pulisher
Oct 02, 2024

Guggenheim’s latest rating for VSTM stock - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Verastem Inc’s results are impressive - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Purchases Shares of 400,000 Verastem, Inc. (NASDAQ:VSTM) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Verastem Inc (VSTM) Stock: A Year of Decreases and Increases - The InvestChronicle

Oct 01, 2024
pulisher
Oct 01, 2024

Guggenheim Initiates Coverage of Verastem (VSTM) with Buy Recommendation - Nasdaq

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Takes Position in Verastem, Inc. (NASDAQ:VSTM) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Verastem's SWOT analysis: oncology firm's stock faces pivotal phase By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

Verastem's SWOT analysis: oncology firm's stock faces pivotal phase - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Verastem (NASDAQ:VSTM) Receives New Coverage from Analysts at Guggenheim - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Guggenheim Initiates Coverage of Verastem (LSE:0LOV) with Buy Recommendation - Nasdaq

Sep 30, 2024
pulisher
Sep 26, 2024

Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Verastem, Inc. (NASDAQ:VSTM) Given Average Recommendation of “Buy” by Analysts - Defense World

Sep 26, 2024
pulisher
Sep 25, 2024

Verastem CFO sells shares worth $257 to cover tax obligations - Investing.com India

Sep 25, 2024
pulisher
Sep 24, 2024

Verastem CFO sells shares worth $257 to cover tax obligations By Investing.com - Investing.com Australia

Sep 24, 2024
pulisher
Sep 24, 2024

Financial Analysis: Verastem Inc (VSTM)’s Ratios Unveil Key Insights - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Does Verona Pharma Plc ADR (NASDAQ: VRNA) Still Look Hot This Week? - Stocks Register

Sep 24, 2024
pulisher
Sep 24, 2024

Verona Pharma Plc ADR (VRNA) deserves closer scrutiny - US Post News

Sep 24, 2024
pulisher
Sep 23, 2024

Evan/ Fa Jones Sells 5,173 Shares of Veracyte, Inc. (NASDAQ:VCYT) Stock - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Stock Surge: Viridian Therapeutics Inc (VRDN) Closes at 22.30, Marking a -0.89 Increase/Decrease - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Are Smart Investors Making the Right Decision? Verastem Inc (VSTM) - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Victory Capital Management Inc. Makes New $527,000 Investment in Savara Inc (NASDAQ:SVRA) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Acadian Asset Management LLC Takes $82,000 Position in Verastem, Inc. (NASDAQ:VSTM) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Verastem CEO sells shares worth $513 to cover tax obligations - Investing.com India

Sep 21, 2024
pulisher
Sep 20, 2024

Verastem CEO sells shares worth $513 to cover tax obligations By Investing.com - Investing.com South Africa

Sep 20, 2024
pulisher
Sep 20, 2024

Verastem director sells shares worth $365 to meet tax obligations By Investing.com - Investing.com Australia

Sep 20, 2024
pulisher
Sep 20, 2024

Verastem director Brian Stuglik sells shares worth $937 By Investing.com - Investing.com South Africa

Sep 20, 2024

Verastem Inc (VSTM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):